Roseola medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Medical therapy== | ==Medical therapy== | ||
The mainstay of therapy for roseola is supportive as HHV 6 typically causes a beningn, self limited illness and antiviral therapy is not indicated. | The mainstay of therapy for roseola is supportive as HHV 6 typically causes a beningn, self limited illness and antiviral therapy is not indicated.{{cite book | last = McInerny | first = Thomas | title = American Academy of Pediatrics textbook of pediatric care | publisher = American Academy of Pediatrics | location = Elk Grove Village, IL | year = 2017 | isbn = 978-1-58110-966-5 }} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:19, 24 May 2017
|
Roseola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Roseola medical therapy On the Web |
|
American Roentgen Ray Society Images of Roseola medical therapy |
|
Risk calculators and risk factors for Roseola medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Medical therapy
The mainstay of therapy for roseola is supportive as HHV 6 typically causes a beningn, self limited illness and antiviral therapy is not indicated.McInerny, Thomas (2017). American Academy of Pediatrics textbook of pediatric care. Elk Grove Village, IL: American Academy of Pediatrics. ISBN 978-1-58110-966-5.